This is a StreetInsider.com Premium Only Page

Ionis Pharmaceuticals (IONS) – StreetInsider.com Reports

Nov 9, 2023 12:43 PM Ionis Pharmaceuticals (IONS) Present Positive Two-year Results from Phase 2 Study of donidalorsen

Nov 6, 2023 03:12 AM Ionis Pharmaceuticals (IONS) PT Raised to $45 at Morgan Stanley

Nov 3, 2023 08:41 AM Ionis Pharmaceuticals (IONS) PT Lowered to $85 at Wells Fargo

Nov 3, 2023 08:30 AM Ionis Pharmaceuticals (IONS) PT Raised to $48 at Morgan Stanley

Nov 3, 2023 06:01 AM Ionis Pharmaceuticals (IONS) PT Raised to $28 at Goldman Sachs

Nov 2, 2023 07:03 AM Ionis Pharmaceuticals (IONS) Reports In-Line Q3 EPS

Oct 23, 2023 06:12 AM BofA Securities Upgrades Ionis Pharmaceuticals (IONS) to Neutral, 'Higher revenue potential'

Sep 28, 2023 04:05 PM Raymond James Starts Ionis Pharmaceuticals (IONS) at Strong Buy

Sep 27, 2023 08:20 AM Ionis Pharmaceuticals (IONS) PT Raised to $45 at Morgan Stanley

Sep 27, 2023 07:00 AM Ionis Pharmaceuticals (IONS) enters agreement with Roche for two novel RNA-targeted programs for Alzheimer's disease and Huntington's disease

Sep 26, 2023 07:01 AM Ionis Pharmaceuticals (IONS) Phase 3 study of olezarsen in people with familial chylomicronemia syndrome met its primary endpoint

Aug 9, 2023 09:07 AM Ionis Pharmaceuticals (IONS) Tops Q2 EPS by 28c; reaffirms guidance

Jul 31, 2023 04:02 AM Citi Upgrades Ionis Pharmaceuticals (IONS) to Buy 'Considering Overall Pipeline Potential'

Jul 28, 2023 07:05 AM Ionis Pharmaceuticals (IONS) Expands eplontersen Deal with AstraZeneca (AZN) to Include Latin America

Jul 17, 2023 11:10 AM BridgeBio unveils positive results from rare heart disease drug trial, shares jump

Jul 10, 2023 07:05 AM Ionis Pharmaceuticals (IONS) Reports Eplontersen Continued to Show Improvement in ATTRv-PN through 85 weeks

Jun 30, 2023 04:09 PM Biogen (BIIB) Presents New Data on SPINRAZA

Jun 8, 2023 05:45 AM Ionis Pharmaceuticals (IONS) Prices $500M Convertible Notes Offering

Jun 7, 2023 04:14 AM Piper Sandler Assumes Ionis Pharmaceuticals (IONS) at Overweight, 'we think shares can work to the $58/sh range'

Jun 6, 2023 04:02 PM Ionis Pharmaceuticals (IONS) announces proposed $500M private placement of convertible notes

Jun 1, 2023 07:10 AM Ionis Pharmaceuticals (IONS) announces positive donidalorsen late-stage clinical progress in HAE

May 4, 2023 07:36 AM Ionis Pharmaceuticals (IONS) PT Lowered to $88 at Wells Fargo

May 4, 2023 06:27 AM Citi Upgrades Ionis Pharmaceuticals (IONS) to Neutral

May 4, 2023 04:22 AM Ionis Pharmaceuticals (IONS) PT Lowered to $37 at Barclays

May 3, 2023 07:18 AM Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 4c

Apr 26, 2023 05:41 AM Ionis Pharmaceuticals (IONS) Announces FDA Approval of QALSODY

Apr 24, 2023 07:01 AM Ionis Pharmaceuticals (IONS) says Eplontersen halted ATTRv-PN disease progression and improved neuropathy impairment and quality of life in Phase 3 study through 66 weeks

Apr 11, 2023 08:23 AM Ionis Pharmaceuticals (IONS) PT Raised to $42 at Morgan Stanley

Mar 27, 2023 05:49 AM Ionis Pharmaceuticals (IONS) Reports Positive 66-week Phase 3 Data for eplontersen

Mar 23, 2023 05:31 AM Ionis Pharmaceuticals (IONS) Reports FDA's AdCom Voted Unanimously for Accelerated Approval of tofersen

Mar 21, 2023 03:09 AM Bernstein Starts Ionis Pharmaceuticals (IONS) at Underperform

Mar 7, 2023 07:06 AM Ionis Pharmaceuticals (IONS) announces FDA acceptance of New Drug Application for eplontersen for the treatment of hereditary transthyretin-mediated amyloid polyneuropathy

Feb 23, 2023 12:14 PM CFRA Upgrades Ionis Pharmaceuticals (IONS) to Hold

Feb 23, 2023 06:44 AM Ionis Pharmaceuticals (IONS) PT Lowered to $67 at BMO Capital

Feb 23, 2023 06:07 AM Ionis Pharmaceuticals (IONS) PT Lowered to $61 at Piper Sandler

Feb 23, 2023 05:53 AM Ionis Pharmaceuticals (IONS) PT Lowered to $40 at Barclays

Feb 23, 2023 03:45 AM Ionis Pharmaceuticals (IONS) PT Lowered to $30 at Citi

Feb 22, 2023 07:23 AM Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 55c

Feb 21, 2023 07:06 AM Ionis Pharmaceuticals (IONS) to Present New donidalorsen Data

Feb 9, 2023 10:58 AM RBC Capital Out Positive on Ionis Pharmaceuticals (IONS)

Feb 1, 2023 09:06 AM Ionis Pharmaceuticals (IONS) Announces GSK Initiates Two Phase 3 Trials for bepirovirsen

Jan 31, 2023 07:07 AM Ionis Pharmaceuticals (IONS) Granted FDA Fast Track Designation for olezarsen

Jan 19, 2023 06:25 AM Ionis Pharmaceuticals (IONS) PT Raised to $62 at Piper Sandler

Jan 9, 2023 09:06 AM Ionis Pharmaceuticals (IONS), Royalty Pharma (RPRX) enter into royalty agreement for up to $1.1 billion

Jan 4, 2023 07:30 AM Biogen (BIIB), Alcyone Therapeutics Announce License and Collaboration Agreement to Evaluate a Novel Device to Improve Patient Experience and Access to Neurological ASO Therapies

Dec 21, 2022 04:33 PM Today's most important downgrades

Dec 21, 2022 12:59 AM Morgan Stanley Downgrades Ionis Pharmaceuticals (IONS) to Equalweight

Dec 20, 2022 12:01 PM 2023 may be the year of the Smid cap in biotech - Piper Sandler

Dec 5, 2022 07:34 AM Ionis Pharmaceuticals (IONS) announces EMA accepts Marketing Authorization Application of tofersen to treat rare, genetic form of ALS

Nov 30, 2022 06:45 AM Ionis Pharmaceuticals (IONS) PT Raised to $32 at SVB Leerink